Select Medical (NYSE:SEM) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Saturday.

According to Zacks, “Select Medical Holdings Corporation, through its subsidiaries, operates specialty hospitals and outpatient rehabilitation clinics. The company’s Specialty Hospital segment offers long-term acute care hospital services and inpatient acute rehabilitative hospital care services. Its Outpatient Rehabilitation segment operates clinics and provides physical, occupational, and speech rehabilitation services. The company also provides medical rehabilitation services on a contract basis to nursing homes, hospitals, assisted living and senior care centers, schools, and work sites. The Mission of Select Medical Corporation is to ensure high-quality health care and cost-effective outcomes by providing specialty inpatient long-term acute care and rehabilitation, and outpatient rehabilitation services. The company is headquartered in Mechanicsburg, Pennsylvania. “

Several other research firms also recently weighed in on SEM. Deutsche Bank restated a “buy” rating and issued a $22.00 price target on shares of Select Medical in a research note on Monday, November 6th. Royal Bank of Canada restated a “buy” rating and issued a $19.00 price target on shares of Select Medical in a research note on Wednesday, September 13th. ValuEngine downgraded Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, October 2nd. Robert W. Baird restated a “buy” rating and issued a $21.00 price target on shares of Select Medical in a research note on Tuesday, October 17th. Finally, Bank of America upgraded Select Medical from an “underperform” rating to a “neutral” rating and set a $19.00 price target for the company in a research note on Thursday. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $19.43.

Shares of Select Medical (NYSE SEM) opened at $18.00 on Friday. The stock has a market cap of $2,410.00, a P/E ratio of 25.00, a P/E/G ratio of 1.15 and a beta of 1.34. Select Medical has a fifty-two week low of $12.00 and a fifty-two week high of $19.77. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 3.36.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, November 2nd. The health services provider reported $0.14 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.16 by ($0.02). The firm had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $1.10 billion. Select Medical had a return on equity of 11.44% and a net margin of 2.21%. The company’s revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the company posted $0.06 earnings per share. analysts predict that Select Medical will post 0.85 earnings per share for the current fiscal year.

In other news, insider Scott A. Romberger sold 5,000 shares of the stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $17.97, for a total transaction of $89,850.00. Following the completion of the transaction, the insider now directly owns 168,211 shares in the company, valued at approximately $3,022,751.67. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Martin F. Jackson sold 134,029 shares of the stock in a transaction that occurred on Friday, December 22nd. The shares were sold at an average price of $17.05, for a total value of $2,285,194.45. Following the transaction, the insider now owns 1,717,944 shares of the company’s stock, valued at $29,290,945.20. The disclosure for this sale can be found here. Insiders sold a total of 314,455 shares of company stock valued at $5,403,144 over the last 90 days. 19.93% of the stock is currently owned by corporate insiders.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in shares of Select Medical by 3.9% during the 2nd quarter. Vanguard Group Inc. now owns 9,929,821 shares of the health services provider’s stock valued at $152,423,000 after acquiring an additional 369,044 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Select Medical by 1.8% during the 3rd quarter. Dimensional Fund Advisors LP now owns 8,289,370 shares of the health services provider’s stock valued at $159,154,000 after acquiring an additional 146,892 shares during the last quarter. Orbimed Advisors LLC boosted its position in shares of Select Medical by 51.3% during the 3rd quarter. Orbimed Advisors LLC now owns 5,578,500 shares of the health services provider’s stock valued at $107,107,000 after acquiring an additional 1,891,100 shares during the last quarter. Northern Trust Corp boosted its position in shares of Select Medical by 14.6% during the 2nd quarter. Northern Trust Corp now owns 2,325,289 shares of the health services provider’s stock valued at $35,694,000 after acquiring an additional 296,087 shares during the last quarter. Finally, Voya Investment Management LLC boosted its position in shares of Select Medical by 24.5% during the 2nd quarter. Voya Investment Management LLC now owns 1,850,668 shares of the health services provider’s stock valued at $28,407,000 after acquiring an additional 364,721 shares during the last quarter. Hedge funds and other institutional investors own 77.89% of the company’s stock.

WARNING: “Select Medical (SEM) Upgraded by Zacks Investment Research to “Hold”” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright law. The original version of this piece of content can be read at https://www.americanbankingnews.com/2018/01/06/select-medical-sem-upgraded-by-zacks-investment-research-to-hold.html.

Select Medical Company Profile

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Get a free copy of the Zacks research report on Select Medical (SEM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.